GO:0005757 mitochondrial permeability transition pore complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005757 describes the mitochondrial permeability transition pore complex (mPTP), a protein complex connecting the inner and outer mitochondrial membranes that can open transiently and allow free diffusion of solutes between the mitochondrial matrix and the cytosol.
• The pore complex is classically formed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D), although the molecular identity of the pore remains an evolving concept.
• Transient opening of the mPTP is physiological, but sustained opening collapses the mitochondrial membrane potential, causes matrix swelling and can trigger cell death.
• The mPTP is a central effector in cardiovascular disease, ischemia-reperfusion injury, platelet biology and aging-related pathology.
• Post-translational modifications of mPTP components, including phosphorylation and acetylation, modulate pore opening in cardiac disease.
• CRISPR knockout, point-mutation, knock-in and overexpression cell models, combined with detection assays, are essential to dissect mPTP component function.
Description
The mitochondrial permeability transition pore complex (mPTP), annotated as GO:0005757, is a protein complex that connects the inner and outer membranes of animal mitochondria and acts as a pore that can open transiently to allow free diffusion of solutes between the mitochondrial matrix and the cytosol. The pore complex is formed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D), and is also known as the mitochondrial PT pore complex, MPTP complex or PTPC. Because opening of this pore is a decisive event in mitochondrial physiology, it has become a focal point for researchers studying cell life and death decisions. The mPTP is not a static structure but an evolving concept whose molecular identity continues to be refined. Its opening is triggered by calcium overload and oxidative stress, and it is modulated by adenine nucleotides, pH and post-translational modifications of its components. In the cardiovascular system, the mPTP has been described as a molecular Achilles heel, and it is also functionally relevant in platelets and in aging. For researchers, GO:0005757 provides a controlled vocabulary anchor for mitochondrial permeability transition studies, linking structural components, regulatory modifications and disease phenotypes. Understanding the composition and assembly of this complex is therefore essential for designing experiments that test causality rather than correlation.
mitochondrial permeability transition pore complex At A Glance
| GO ID | GO:0005757 |
|---|---|
| GO term | mitochondrial permeability transition pore complex |
| Ontology | cellular_component |
| Synonym | mitochondrial PT pore complex; MPTP complex; PTPC |
| Major function | Transient pore allowing free diffusion of solutes between the mitochondrial matrix and the cytosol |
| Classical components | Voltage-dependent anion channel (VDAC), adenine nucleotide translocase (ANT), cyclophilin-D (CyP-D) |
| Location | Inner and outer mitochondrial membranes of animal mitochondria |
| Regulatory triggers | Calcium overload, oxidative stress, adenine nucleotides, pH and post-translational modifications |
| Disease relevance | Cardiovascular disease, ischemia-reperfusion injury, platelet dysfunction and aging |
What Is GO:0005757?
GO:0005757 (mitochondrial permeability transition pore complex) is a cellular component ontology term describing a protein complex that spans and connects the inner and outer membranes of animal mitochondria. It functions as a pore that can open transiently, permitting free diffusion of solutes between the mitochondrial matrix and the cytosol. The complex is classically described as being formed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D). Synonyms include mitochondrial PT pore complex, MPTP complex and PTPC.
Why Is mitochondrial permeability transition pore complex Important in Cell Biology?
The mPTP is important because its opening is a point of no return in mitochondrial physiology: transient opening participates in normal signaling, whereas sustained opening dissipates the mitochondrial membrane potential, causes matrix swelling and can commit cells to death. This dual role makes GO:0005757 a critical node for understanding cell life and death decisions, and it explains why the complex is implicated in cardiovascular disease, ischemia-reperfusion injury, platelet function and aging. Because post-translational modifications of mPTP components modulate pore opening, the complex is also a target for mechanistic and therapeutic research.
• The mPTP is a central regulator of mitochondrial permeability and cell death.
• Transient opening is physiological, while sustained opening causes mitochondrial swelling and dysfunction.
• The complex is a molecular Achilles heel in cardiovascular disease.
• It contributes to ischemia-reperfusion injury and cardiac pathology.
• It has physiological and therapeutic relevance in platelets.
• mPTP opening activates the mitochondrial unfolded protein response and promotes aging.
• Post-translational modifications of mPTP components are associated with cardiac diseases.
• Protectors of the mPTP can be activated by iron and doxorubicin, linking the pore to cancer drug responses.
• Detection assays for mPTP opening are essential for experimental readouts.
• The molecular identity of the pore remains an evolving concept, motivating continued research.
What Happens During mitochondrial permeability transition pore complex?
Triggering of pore opening
In simple terms: The pore opens when mitochondria are stressed, especially by too much calcium or oxidative stress.
Opening of the mPTP is triggered by calcium overload and oxidative stress, conditions that are common in injured or stressed cells. These triggers convert the complex from a closed to an open state, allowing solutes to move freely across the inner membrane.
Transient versus sustained opening
In simple terms: A brief opening can be reversible, but a long opening damages the mitochondrion.
The pore can open transiently to allow free diffusion of solutes between the mitochondrial matrix and the cytosol. Transient opening may participate in physiological signaling, whereas sustained opening collapses the mitochondrial membrane potential and causes matrix swelling.
Consequences for mitochondrial function
In simple terms: When the pore stays open, mitochondria lose their driving force and swell.
Sustained mPTP opening dissipates the mitochondrial membrane potential and leads to mitochondrial swelling and dysfunction. This can commit cells to death and is a critical event in cell life and death decisions.
Signaling to the mitochondrial unfolded protein response
In simple terms: Pore opening can send a stress signal to the nucleus.
The mPTP activates the mitochondrial unfolded protein response and promotes aging, linking pore opening to a mitochondrial-to-nuclear stress signaling pathway.
Key Genes Involved in GO:0005757 mitochondrial permeability transition pore complex
The following genes and proteins are the principal components and regulators of the mitochondrial permeability transition pore complex (GO:0005757) described in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VDAC1 | Voltage-dependent anion channel in the outer mitochondrial membrane; classical mPTP component | Outer membrane pore component; target for mPTP assembly studies |
| VDAC2 | Voltage-dependent anion channel isoform; outer membrane component | Isoform-specific roles in mitochondrial permeability |
| VDAC3 | Voltage-dependent anion channel isoform; outer membrane component | Less characterized isoform in mPTP biology |
| ANT1 (SLC25A4) | Adenine nucleotide translocase; inner membrane component | Classical mPTP component; adenine nucleotide exchange |
| ANT2 (SLC25A5) | Adenine nucleotide translocase isoform; inner membrane component | Isoform-specific regulation of pore opening |
| ANT3 (SLC25A6) | Adenine nucleotide translocase isoform; inner membrane component | Contributes to inner membrane permeability |
| PPIF (CyP-D) | Cyclophilin-D; peptidyl-prolyl isomerase that sensitizes the pore | Classical mPTP regulator; target of cyclosporin A |
| PPIA (CyP-A) | Cyclophilin A; related peptidyl-prolyl isomerase | Modulates mitochondrial permeability in stress |
| ATP5F1B | ATP synthase subunit; proposed to contribute to pore formation | Candidate structural component in evolving mPTP models |
| ATP5F1A | ATP synthase subunit; proposed to contribute to pore formation | Candidate structural component in evolving mPTP models |
| SPG7 | Mitochondrial protease; modulates mPTP opening | Regulator of pore sensitivity |
| SLC25A3 | Phosphate carrier; inner membrane transporter | Modulates matrix calcium and pore opening |
| BCL2 | Anti-apoptotic protein; interacts with mitochondrial membranes | Modulates cell death downstream of mPTP |
| BAX | Pro-apoptotic protein; permeabilizes outer membrane | Cooperates with mPTP in cell death |
| GSK3B | Kinase; phosphorylates mPTP-related targets | Post-translational regulation of pore opening |
| PRKCE | Protein kinase C epsilon; modulates mPTP opening | Cardioprotective signaling to the pore |
| SIRT3 | Mitochondrial deacetylase; modifies mPTP component acetylation | Post-translational regulation of pore opening |
| TP53 | Tumor suppressor; influences mitochondrial permeability | Links mPTP to stress and cancer biology |
How Is mitochondrial permeability transition pore complex Regulated?
The mPTP is regulated by calcium and oxidative stress, which trigger opening, and by adenine nucleotides, pH and post-translational modifications of its components, which modulate sensitivity. Post-translational modifications of mPTP complex proteins, including phosphorylation and acetylation, are associated with cardiac diseases and provide a layer of regulatory control. Cyclophilin-D (CyP-D) sensitizes the pore, and its inhibition by cyclosporin A is a classical experimental manipulation. Protectors of the mPTP can be activated by iron and doxorubicin, indicating that pharmacological and redox signals converge on the complex.
mitochondrial permeability transition pore complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPIF (CyP-D) | Cardiovascular disease; mPTP sensitization | PPIF knockout and point-mutation cell models |
| SLC25A4 (ANT1) | Cardiac disease; inner membrane permeability | SLC25A4 knockout and knock-in models |
| VDAC1 | Ischemia-reperfusion injury; outer membrane permeability | VDAC1 knockout and overexpression models |
| SIRT3 | Cardiac disease; acetylation-dependent regulation | SIRT3 knockout and overexpression models |
| TP53 | Cancer; mitochondrial permeability and cell death | TP53 knockout and point-mutation models |
Cardiovascular disease
The mPTP has been described as the cardiovascular disease's molecular Achilles heel, and its opening is a critical event in cardiac injury. Post-translational modifications of mPTP complex proteins are associated with cardiac diseases, linking the complex to disease mechanisms. Because sustained opening collapses the mitochondrial membrane potential and causes swelling, it contributes to cardiomyocyte death in ischemia-reperfusion injury.
Platelet biology and thrombosis
The mPTP has physiological roles in platelets and is a therapeutic perspective for platelet-related conditions. Its mechanisms in platelets connect mitochondrial permeability to platelet function and to potential therapeutic interventions.
Aging
The mPTP activates the mitochondrial unfolded protein response and promotes aging, providing a mechanistic link between pore opening and age-related decline. This positions the complex as a node where mitochondrial stress signaling influences organismal aging.
Cancer and drug response
Protectors of the mPTP can be activated by iron and doxorubicin, indicating that the complex participates in responses to cancer chemotherapeutics. Because mPTP opening can commit cells to death, modulating the pore is relevant to cancer cell survival and drug sensitivity.
From mitochondrial permeability transition pore complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PPIF required for mPTP opening? | PPIF knockout cell line |
| Does a specific phosphorylation site regulate pore opening? | Point-mutation knock-in of the target residue |
| Does a disease-associated variant alter mPTP sensitivity? | Knock-in of the patient variant |
| Where and when is an mPTP component expressed? | Tagged knock-in with a fluorescent or affinity tag |
| Does increased expression of a component sensitize cells to death? | Overexpression cell model |
| Which genes modify mPTP-dependent phenotypes? | CRISPR library screening with bioinformatics analysis |
How to Study the mitochondrial permeability transition pore complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| mPTP detection assays | Pore opening and mitochondrial swelling | Functional readout of GO:0005757 |
| Post-translational modification profiling | Phosphorylation and acetylation of mPTP components | Cardiac disease mechanism studies |
| Cyclosporin A sensitivity test | CyP-D-dependent pore opening | Pharmacological validation of mPTP involvement |
| Mitochondrial membrane potential measurement | Loss of membrane potential upon sustained opening | Cell death and stress studies |
| Mitochondrial swelling assay | Matrix swelling after pore opening | Isolated mitochondria experiments |
| Mitochondrial unfolded protein response reporters | Stress signaling activated by mPTP | Aging and proteostasis studies |
| CRISPR library screening | Genes modifying mPTP-dependent phenotypes | Discovery of novel regulators |
| Bioinformatics pathway analysis | Enrichment of mPTP-related gene sets | Interpretation of screening and omics data |
Detection assays for mPTP opening
Detection assays of the mitochondrial permeability transition pore are essential for measuring pore opening in cells and mitochondria, and their current status and future prospects have been reviewed. These assays provide the functional readout that anchors mechanistic studies of GO:0005757.
Post-translational modification analysis
A systematic review of post-translational modifications in the mPTP complex associated with cardiac diseases highlights the importance of mapping phosphorylation, acetylation and related modifications on pore components. Such analyses connect structural changes in the complex to functional outcomes.
Genetic and pharmacological perturbation
Cyclophilin-D inhibition by cyclosporin A is a classical pharmacological manipulation of the pore, and genetic perturbation of components such as VDAC and ANT provides complementary evidence. Protectors of the mPTP activated by iron and doxorubicin offer additional chemical tools.
Mitochondrial stress and aging readouts
Because mPTP opening activates the mitochondrial unfolded protein response and promotes aging, mitochondrial stress reporters and aging assays are useful readouts for pore activity. These methods link molecular pore opening to cellular and organismal phenotypes.
How CRISPR Can Be Used to Study GO:0005757 mitochondrial permeability transition pore complex
Knockout
CRISPR knockout of mPTP component genes such as PPIF, VDAC1 or SLC25A4 can test whether a candidate component is required for pore opening and downstream phenotypes. Knockout models are particularly useful when combined with detection assays that measure pore opening directly.
Point Mutation
Point-mutation models can test whether specific residues, such as phosphorylation or acetylation sites on mPTP components, regulate pore opening. These models help distinguish site-specific regulation from loss-of-protein effects.
Knock-in
Knock-in of disease-associated variants or tagged alleles allows researchers to study mPTP component localization, interactions and variant-specific effects. Tagged knock-in lines are valuable for imaging and proteomic analysis of the complex.
Overexpression
Overexpression of mPTP components can test whether increased protein levels sensitize cells to permeability transition and death. Such models complement knockout studies by probing gain-of-function effects.
How EDITGENE Supports mitochondrial permeability transition pore complex Research
Researchers studying mitochondrial permeability transition pore complex-related genes often need to determine whether a candidate gene is causally involved in pore opening, mitochondrial dysfunction or disease phenotypes. Because the mPTP is an evolving concept with multiple proposed components and regulators, rigorous genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial permeability transition pore complex research.
Frequently Asked Questions About mitochondrial permeability transition pore complex
What is the mitochondrial permeability transition pore complex?
It is a protein complex annotated as GO:0005757 that connects the inner and outer mitochondrial membranes and can open transiently to allow free diffusion of solutes between the mitochondrial matrix and the cytosol.
What genes are involved in the mitochondrial permeability transition pore complex?
Classical components include the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D), encoded by genes such as VDAC1, SLC25A4 and PPIF.
What is GO:0005757?
GO:0005757 is the Gene Ontology cellular component term for the mitochondrial permeability transition pore complex, also known as the mitochondrial PT pore complex, MPTP complex or PTPC.
Why is the mPTP important in cardiovascular disease?
The mPTP has been described as the cardiovascular disease's molecular Achilles heel, and its opening is a critical event in cardiac injury and ischemia-reperfusion.
How is mPTP opening regulated?
Opening is triggered by calcium overload and oxidative stress and is modulated by adenine nucleotides, pH and post-translational modifications of pore components.
What happens when the mPTP opens for a long time?
Sustained opening collapses the mitochondrial membrane potential, causes matrix swelling and can commit cells to death.
Is the mPTP involved in aging?
Yes, mPTP opening activates the mitochondrial unfolded protein response and promotes aging.
What assays detect mPTP opening?
Detection assays of the mitochondrial permeability transition pore measure pore opening and mitochondrial swelling, and their current status has been reviewed.
Can CRISPR be used to study mPTP components?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can test the causal roles of mPTP components and their regulatory residues.
What is cyclophilin-D and why does it matter?
Cyclophilin-D (CyP-D, encoded by PPIF) is a classical mPTP component that sensitizes the pore and is inhibited by cyclosporin A.
Conclusion
GO:0005757 describes the mitochondrial permeability transition pore complex, a dynamic complex of VDAC, ANT and cyclophilin-D that connects the inner and outer mitochondrial membranes and can open transiently to allow solute diffusion. Its opening is a decisive event in cell life and death, and it is implicated in cardiovascular disease, platelet biology, aging and cancer drug responses. Because the molecular identity of the pore remains an evolving concept, rigorous genetic models and detection assays are essential to dissect its components and regulation. CRISPR knockout, point-mutation, knock-in and overexpression cell models, combined with library screening and bioinformatics, provide a practical route to test causality for mPTP-related genes.
References
- 1. Nesci S et al.. 2025. Mitochondrial Permeability Transition Pore: The Cardiovascular Disease's Molecular Achilles Heel.. Biomedicines 13(12) PMID: 41463026
- 2. Morciano G et al.. 2021. The mitochondrial permeability transition pore: an evolving concept critical for cell life and death.. Biol Rev Camb Philos Soc 96(6):2489-2521 PMID: 34155777
- 3. Lonobile C et al.. 2025. The Mitochondrial Permeability Transition Pore in Platelets: Mechanisms, Physiological Roles, and Therapeutic Perspectives.. Antioxidants (Basel) 14(8) PMID: 40867821
- 4. Alves-Figueiredo H et al.. 2021. A systematic review of post-translational modifications in the mitochondrial permeability transition pore complex associated with cardiac diseases.. Biochim Biophys Acta Mol Basis Dis 1867(1):165992 PMID: 33091565
- 5. Crompton M et al.. 1999. The mitochondrial permeability transition pore.. Biochem Soc Symp 66:167-79 PMID: 10989666
- 6. Fedotcheva TA et al.. 2021. Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin.. Curr Cancer Drug Targets 21(6):514-525 PMID: 33475063
- 7. Hong D et al.. 2025. Detection assays of mitochondrial permeability transition pore: Current status and future prospects.. Acta Histochem 127(3):152278 PMID: 40763584
- 8. Angeli S et al.. 2021. The mitochondrial permeability transition pore activates the mitochondrial unfolded protein response and promotes aging.. Elife 10 PMID: 34467850
